Healthcare Policy and Biopharmaceutical Concerns

Patients and experts are concerned about new Medicaid work rules, particularly the difficulty in obtaining a ‘medically frail’ exemption. Additionally, there is an opinion piece highlighting U.S. dependence on China in biopharmaceuticals as a national security risk.